SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $70 | -99.9% | 79,200 | +14.6% | 0.00% | -100.0% |
| Q3 2022 | $108,000 | -22.3% | 69,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $139,000 | -13.7% | 69,100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $161,000 | -49.8% | 69,100 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $321,000 | -31.4% | 69,100 | +12.7% | 0.00% | 0.0% |
| Q3 2021 | $468,000 | -21.2% | 61,300 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $594,000 | +61.4% | 61,300 | +37.8% | 0.00% | +50.0% |
| Q1 2021 | $368,000 | +21.1% | 44,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $304,000 | – | 44,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |